UNI MEDICAL (02666) plans to issue a total principal amount of up to 600 million yuan of corporate bonds.
Global Medical (02666) announced that its wholly-owned subsidiary, China Global Leasing Limited (Issuer)...
UNI MEDICAL(02666) announces that its wholly-owned subsidiary, China Global Leasing Co., Ltd. (the issuer), has received approval from the China Securities Regulatory Commission (CSRC) to publicly issue up to RMB 8 billion in domestic corporate bonds for qualified investors in China. As of the date of this announcement, the remaining quota for the bonds is RMB 6.5 billion. The bonds will be issued in stages, and the issuer's total issuance amount for the second series of corporate bonds in 2025 (this series of bonds) will not exceed RMB 600 million (including RMB 600 million). The bonds have a base term of five years, with the issuer having redemption options at the end of the first, second, third, and fourth years, as well as the right to adjust the face interest rate and the right for investors to sell back.
 Related Articles 

Pangang Group Vanadium & Titanium Resources (000629.SZ) has accumulated bought back 36.35 million shares, spending 101 million yuan.

Yum China (YUMC.US) recorded an 8% year-on-year growth in operating profit, and same-store transaction volume has continued to increase for the 11th consecutive quarter.

ZYLOXTB(02190) spent 1.1674 million Hong Kong dollars to repurchase 50,000 shares on November 4th.
Pangang Group Vanadium & Titanium Resources (000629.SZ) has accumulated bought back 36.35 million shares, spending 101 million yuan.

Yum China (YUMC.US) recorded an 8% year-on-year growth in operating profit, and same-store transaction volume has continued to increase for the 11th consecutive quarter.

ZYLOXTB(02190) spent 1.1674 million Hong Kong dollars to repurchase 50,000 shares on November 4th.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


